Business Context and Reporting Period
Company: Kimberly-Clark Corporation (KMB)
Filing Type: Form 8-K (Current Report)
Date: December 10, 2024
Event: Change in Reportable Segments
In the fourth quarter of 2024, Kimberly-Clark realigned its internal operating structure to streamline the supply chain and improve overhead efficiency. The company transitioned from a product-based reporting model (Personal Care, Consumer Tissue, K-C Professional) to a geographic and product hybrid model. The new reportable segments are:
- North America (NA)
- International Personal Care (IPC)
- International Family Care and Professional (IFP)
Historical financial data has been recast to reflect this new structure for periods dating back to 2021. These changes do not impact consolidated financial results.
Key Financial Metrics (Recast)
The following data reflects the new segment structure for the nine months ended September 30, 2024, and the full year ended December 31, 2023 (in millions).
| Segment | Net Sales (9M 2024) | Net Sales (FY 2023) | Operating Profit (9M 2024) | Operating Profit (FY 2023) |
|---|---|---|---|---|
| North America (NA) | $8,286 | $10,988 | $1,986 | $2,507 |
| Int'l Personal Care (IPC) | $4,340 | $5,899 | $632 | $632 |
| Int'l Family Care & Prof (IFP) | $2,504 | $3,544 | $288 | $287 |
| Total Segment Operating Profit | $2,906 | $3,426 | $2,906 | $3,426 |
| Corporate & Other | ($244) | ($1,082) | (244) | (1,082) |
| Total Operating Profit (GAAP) | $2,662 | $2,344 | $2,662 | $2,344 |
Note: Total Segment Operating Profit is a non-GAAP measure excluding unallocated corporate expenses and one-time items.
Material Changes vs. Prior Period
Revenue Trends (9 Months Ended Sept 30, 2024 vs. Prior Year):
- Consolidated Net Sales: Decreased by 2.1% total, driven by a 4.4% negative impact from currency translation and 1.2% from divestitures. Organic sales (volume, mix, price) increased by 3.5%.
- North America: Sales declined 0.4% total. Organic growth was 1.0%, offset by currency and divestiture impacts.
- International Personal Care (IPC): Sales declined 3.7% total. Strong organic growth of 10.4% was significantly offset by a 14.0% negative currency impact.
- International Family Care (IFP): Sales declined 7.4% total. Organic sales decreased 0.5%, with significant headwinds from divestitures (-5.0%) and currency (-1.9%).
Profitability: Total Operating Profit for the nine months ended September 30, 2024, was $2,662 million, an increase from $2,344 million in the same period of 2023. This improvement is largely attributed to a reduction in "Corporate & Other" expenses from $1,082 million in 2023 to $244 million in 2024.
Guidance, Outlook, and Risks
Management Commentary: The segment realignment is designed to drive growth and profitability by aligning with how the Chief Operating Decision Maker (CODM) evaluates global strategies. The new profitability measure includes exchange rate effects on monetary assets/liabilities for subsidiaries in highly inflationary economies.
Forward-Looking Risks: The filing highlights several risks that could impact future results:
- Transformation Initiative: Risks related to realizing anticipated cost savings and volume increases from the 2024 Transformation Initiative.
- Geopolitical Instability: Wars in Ukraine and Israel, and related sanctions or consumer responses.
- Macroeconomic Factors: Fluctuations in foreign currency exchange rates (specifically Argentina and Türkiye), raw material and energy costs, and supply chain disruptions.
- Market Conditions: Competitive pressures on pricing, changes in customer preferences, and severe weather conditions.
Unusual Items: The "Corporate & Other" line item includes unallocated general corporate expenses, impairment charges, and costs related to reorganization activities. The significant variance in this line between 2023 and 2024 impacts the GAAP operating profit comparison.
Investor Verification Checklist
- Segment Recasting: Verify that historical comparisons are made using the recast data provided in Exhibit 99.1, not the original 10-Q filings which used the old segment structure.
- Currency Impact: Assess the magnitude of the currency headwinds (approx. 4.4% negative impact on 9M 2024 sales) and the specific exposure in highly inflationary economies like Argentina and Türkiye.
- Divestiture Effects: Confirm the specific impact of the Brazil tissue, K-C Professional, and PPE business exits on the IFP and IPC segments.
- Corporate Expense Volatility: Review the reconciliation of "Corporate & Other" expenses to understand the one-time charges or savings driving the improvement in GAAP operating profit.
- Non-GAAP Measures: Ensure analysis distinguishes between "Total Segment Operating Profit" (non-GAAP) and "Total Operating Profit" (GAAP) when evaluating segment performance.